Since 2013, we have been heavily investing in CRISPR/Cas9-based cell line development, and have designed a unique offer, combining our:

  • Expertise in genetic design
  • Rigorous quality controls for cell lines

With the advantages of gene editing technologies, such as:

  • Cost effectiveness
  • Short development time
"We are applying CRISPR/Cas9 technology to create genetic modifications (Knockouts, Knockins)
to your chosen in-house cell line."

‍

You will benefit from:

  • Freedom to operate thanks to our unique IP portfolio, including a license from Broad Institute (MIT)
  • Off-target measurement
  • Short development time
More info

CRISPR/Cas9-based cell line development

Get in touch about

Let us know how we can help

Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe